Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In the trial the effectiveness of pre-briefing physicians with the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physician's clinical performances is investigated.
Status epilepticus (SE) is a life-threatening neurological emergency defined as a state of continuous seizure or multiple seizures without full recovery of sensory, motor and/or cognitive function for at least 30 minutes. To achieve high quality management of SE, the American Epilepsy Society published an evidence-based guideline for the treatment of SE, which serves as reference for most national guidelines, but analyses regarding practicability, strict adherence, correct translation into clinical practice, and identification of recommended treatment steps at risk of being modified or missed are lacking. Simulator-based studies offer a platform for the design of standardized clinical scenarios that enable detailed investigations regarding the effect of the implementation and practicability of treatment guidelines.
This randomized controlled intervention study performed at the simulation center of the medical intensive care units (ICUs) at the University Hospital Basel is to investigate the effectiveness of pre-briefing physicians with both the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physicians' clinical performances..
Physicians from different medical specialties and with different duration of clinical experience will be enrolled. Participants will be randomly assigned to one of the following three pre-briefing groups: (1) no pre-briefing prior to the simulation training; (2) pre-briefing with the current SE treatment guidelines; (3) pre-briefing with the consolidated "one page" SE treatment guideline.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| No pre-briefing prior to the simulation training | Placebo Comparator | No pre-briefing prior to the simulation training |
|
| Pre-briefing with the current SE treatment guidelines | Active Comparator | pre-briefing with the current SE treatment Guidelines published by the American Epilepsy Society |
|
| pre- briefing with consolidated SE treatment guideline | Active Comparator | pre-briefing with the consolidated "one page" SE treatment guideline |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pre-briefing with the current SE treatment guidelines | Other | instruction of the study participants according to the evidence-based guideline for the treatment of SE published by the American Epilepsy Society prior to the simulation training |
| Measure | Description | Time Frame |
|---|---|---|
| Time to SE recognition (minutes) | time to recognition of seizure and/or SE | from start of simulation training until recognition of seizure and/or SE (max. 20 minutes) |
| Measure | Description | Time Frame |
|---|---|---|
| administration of anti-seizure medication | time of administration of anti-seizure medication (minutes) | within the first 20 minutes after beginning of the simulation training |
| dose of anti-seizure medication |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Raoul Sutter, PD Dr. MD | Clinic for Intensive Care Medicine, University Hospital Basel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinic for Intensive Care Medicine, University Hospital Basel | Basel | 4031 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D013226 | Status Epilepticus |
| ID | Term |
|---|---|
| D012640 | Seizures |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Pre-briefing with a consolidated "one page" SE treatment guide | Other | instruction of the study participants with a consolidated "one page" SE treatment guide prior to the simulation training |
|
| No Pre-briefing | Other | no instruction of the study participants prior to the simulation training |
|
dose of anti-seizure medication (mg)
| within the first 20 minutes after beginning of the simulation training |
| time to correct airways protection | time to correct airways protection (minutes) | from start of simulation training until correct airways protection (max. 20 minutes) |
| quantification of Glasgow Coma Score (GCS) | GCS is a neurological scale recording the state of a person's consciousness ; The scale is composed of three tests: eye, verbal and motor responses. The three values separately as well as their sum are considered. The lowest possible GCS (graded 1 in each element) is 3 (deep coma or death), while the highest is 15 (fully awake person). | within the first 20 minutes after beginning of the simulation training |
| D013568 |
| Pathological Conditions, Signs and Symptoms |